Neramexane (merz pharmaceuticals/forest laboratories).

Article Details

Citation

Rammes G, Schierloh A

Neramexane (merz pharmaceuticals/forest laboratories).

IDrugs. 2006 Feb;9(2):128-35.

PubMed ID
16523403 [ View in PubMed
]
Abstract

Merz Pharmaceuticals GmbH and Forest Laboratories Inc are developing neramexane, an oral N-methyl-D-aspartate antagonist, as a potential neuroprotectant for various central nervous system disorders, including Alzheimer's disease, and for the potential treatment of drug and alcohol dependence, and pain.

DrugBank Data that Cites this Article

Drugs